Aker BioMarine Launches Vitality Month 2026 in Frankfurt with “Braingevity: Brain Power for Healthy Ageing”

LYSAKER , NORWAY, June 8, 2026 /EINPresswire.com/ -- Aker BioMarine is officially debuting Vitality Month 2026 in Frankfurt with Braingevity: Brain Power for Healthy Ageing, a dedicated event featuring leading experts, innovators, and brands to explore the future of cognitive health, healthy ageing, and precision nutrition.

Braingevity: Brain Power for Healthy Ageing will be held at Place to Be Frankfurt, Westend Tower on June 9th. The program opens with Michael Hempel of Aker BioMarine, followed by a presentation from Joris DeWit of Accretio Ventures on the growing “braincare” trend. Christine Strømhylden will discuss precision nutrition for the brain, while Christian Heck of Lonza/Capsugel will present dosage form solutions for brain health and mental performance.

Afternoon sessions feature Oliver Romanow of Kaneka Nutrients Europe on mitochondrial health and ageing, and Stefan Victor Braun of ImperialOel on the gut–brain axis and plant-based omega-3s. The program also includes presentations from Philipp Stadel of Sirio Pharma on creating consumer experiences around healthy brains, Robert Alber of Alzchem on creatine for cognitive performance, and Jörg Büttinghaus of BP52 Brand Development on the value of branded ingredients.

“Frankfurt sets the tone for Vitality Month 2026 by bringing together some of the most forward-thinking voices in the industry,” said Mercè Piñol, SVP sales human health ingredients EMEA at Aker BioMarine. “With Braingevity, we want to spotlight the growing importance of brain health innovation and active minds as part of our wider active wellness theme. We are also excited to preview Lysoveta, Aker BioMarine’s brain health ingredient, with our partners in Germany ahead of its anticipated introduction in the EU market, subject to EFSA approval. Designed to support long-term brain health and healthy ageing, Lysoveta represents an important step forward in Aker BioMarine’s brain health innovation journey.”

This year’s Vitality Month theme, Active Body, Active Mind, highlights the growing connection between physical vitality, brain health, and nutritional innovation, highlighting the latest scientific research shaping the future of nutraceutical innovation. Attendees will gain insights into Aker BioMarine’s innovative, science-backed ingredient portfolio, including Lysoveta, Superba Krill oil, and Revervia. Superba Krill oil helps support an active body by promoting metabolism, muscle health, recovery, heart health, and overall vitality, while Revervia delivers one of the highest natural concentrations of algae-based DHA to support brain, eye, and maternal health, as well as overall wellbeing.

Beyond the Braingevity: Brain Power for Healthy Ageing event in Frankfurt, the series continues in Milan on June 16 with Active Body, Active Mind through Science, Innovation & Industry Perspectives, held in collaboration with Barentz. It then moves to Barcelona on June 19 and Madrid on June 22, both featuring the Open Trail Team and held in collaboration with Comercial Química Massó. On July 1, the event arrives in Istanbul with a focus on Women’s Health & Sleep Health in collaboration with Dekoba.

Registration is now open for all in-person Vitality Month 2026 events. Attendees can sign up to receive updates on featured speakers, agenda highlights, and event details in each city.

About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops sustainable marine-based health ingredients. By harnessing the natural, nutritional power of Krill and Algae, Aker BioMarine has a unique position in its industry by helping address global health challenges, such as Omega-3 deficiencies. The ingredient portfolio consists of Superba Krill® Oil, Lysoveta®, Revervia®, and PL+™, as well as the consumer brand, Kori® Krill Oil. The innovative approach also extends into the spin-offs AION® (reduce and recycle plastic waste across industries) and Understory® (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

Lisa A Miller
Aker BioMarine ASA
lisa.miller@akerbiomarine.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.